Pharmafile Logo

Does being an independent agency really matter?

February 9, 2022 |  

With Cuttsy+Cuttsy ranked as #6 in the Independent Agencies listing from PM Live’s T40 Creative Healthcare Agencies 2021, Mathew Cutts reflects on what being ‘independent’ means to him.

Cuttsy+Cuttsy was recently ranked the number 6 Independent Agency in PM Live’s Top 40 Creative Healthcare Agencies listing. It’s great to feature on the list and a huge endorsement for the agency which we are proud to have grown independently over the past 10 years. But the recent listing made us stop and think about what it means to be independent, and whether it really matters to the people we work with on healthcare communication projects. The answer to the question probably depends on who you are, but here’s my take on why it’s always worth considering an independent agency.

It’s personal

How often do you go to a pitch from an agency, get wowed, sign them up, only for your project to be handed over to another team to deliver it? At an independent agency this is MUCH less likely to happen — the people you meet at the pitch will be by your side as you work together to navigate every step of your project. Working closely with you, they’ll be able to tailor the programme to your exact business needs and if a project needs some specialist resources, an independent agency is not beholden to a head office dictating that you must use a sister agency (regardless of your best interests).

Nimble yet decisive

When you’re looking for a partner agency, it’s worth considering the size of the agency — too small and you may not have access to the skills and resources you require, too large and it may take more time to get your project delivered as materials are held up in time consuming internal processes. A mid-size independent often strikes a good balance, offering agility and responsiveness to project delivery while retaining a proximity to leadership teams (typically the founders) who can make decisions about resources and investment in the business and implement them the same day.

The bigger picture

At the beginning of my career, I was told to join a small business early on (to get experience of a broader role) and a bigger one later, as a way of speeding up my career path. While that may be worthy career advice, it also reflects the diversity of experience that working at independent agencies offers. That experience translates into knowledge and wisdom that can be applied to every new project and challenge. The fact that our team is so closely involved with every aspect of their projects, means that between us there is very little that we have not encountered before!

I am sure there are many other reasons for working with independent agencies and the larger networks. But right now, I am proud to be one of the founders of PM Live’s T40 top independent agencies 2021.

Mathew

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Permission to pause: making treatment breaks part of the cancer care conversation

Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.

A seat at the table: what the EU HTA reforms really ask of patient involvement

The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.

Why faster trials make participant understanding more important than ever

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.

Older trial participants reject bad design, not technology

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.

5 key takeaways from the Patient Centricity and Engagement Conference

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

It’s time to stop calling adverse events ‘manageable’

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

The value: why localisation pays off across global trials

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

The solution: Good localisation doesn’t feel translated

Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.

Healthcare information is becoming easier to access. Trust isn’t.

Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.

It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment

ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.